Last month, the Food and Drug Administration (FDA) approved another in a series of medicines that have dramatically changed the outlook for those diagnosed with hepatitis C. Epclusa is a single pill taken once a day for 12 weeks. It is the first drug to clear all six strains of the virus in up to 99 percent of patients. It also is the latest direct acting antiviral — a drug that stops the virus from replicating itself. Previous drugs worked by helping the body fight off the infection.
Written by Rose Rimler on 7/12/16
